Effects of Motor Imagery in Pain Modulation and Median Nerve Mechanosensitive in Healthy Patients

June 7, 2021 updated by: Josue Fernandez Carnero, Universidad Rey Juan Carlos
The aim of this study are 1) to determinate the effectiveness of motor imagery or strength training in differens aspects of pain modulation. 2) evaluate the functional improvement of the hand by a motor imagery protocol.

Study Overview

Study Type

Interventional

Enrollment (Actual)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Madrid
      • Alcorcón, Madrid, Spain, 28922
        • Universidad Rey Juan Carlos

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Healthy

Exclusion Criteria:

  • be under 18
  • any pathology which provoke pain.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Action observation
The patients will observe a 25 minutes clip of neurodynamic exercises of the hand.
With a mirror glasses on, do the neurodynamic exercises with the non-dominant hand while the patient is looking at the dominant hand
active movement of the dominant hand. Do neurodynamic exercises.
Execute a short strength training for the dominant hand
Experimental: Mirror Therapy
With a mirror glasses, the patients will execute neurodynamic movements of their non-dominant hand during 25 minutes.
active movement of the dominant hand. Do neurodynamic exercises.
Execute a short strength training for the dominant hand
look at a clip of a hand doing neurodynamic exercises.
Active Comparator: Strength Training
Strength protocol for the dominant hand.
With a mirror glasses on, do the neurodynamic exercises with the non-dominant hand while the patient is looking at the dominant hand
active movement of the dominant hand. Do neurodynamic exercises.
look at a clip of a hand doing neurodynamic exercises.
Experimental: Neurodynamic exercise
Active neurodynamic exercises for the dominant hand.
With a mirror glasses on, do the neurodynamic exercises with the non-dominant hand while the patient is looking at the dominant hand
Execute a short strength training for the dominant hand
look at a clip of a hand doing neurodynamic exercises.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Conditioned pain modulation
Time Frame: Change from baseline at 2 weeks
Diffused noxious inhibitory control system will be measure with tourniquet test
Change from baseline at 2 weeks
Pressure pain threshold
Time Frame: Change from baseline at 2 weeks
Three consecutive trials of pressure pain threshold on the active trigger point at a rate of 1 kg/sec at intervals of 30 seconds were conducted.
Change from baseline at 2 weeks
Cold hyperalgesia
Time Frame: Change from baseline at 2 weeks
10 seconds of a cold pack and after that, rating the pain from 0 to 10
Change from baseline at 2 weeks
Neural mechanosensitive
Time Frame: Change from baseline at 2 weeks
Upper Limb Neurodynamic test 1 (ULNT1)
Change from baseline at 2 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Strength_grip
Time Frame: Change from baseline at 2 weeks
grip strength without pain
Change from baseline at 2 weeks
Imagine movement capacity
Time Frame: Change from baseline at 2 weeks

testing the capacity of imagine that their own body is movement. Movement Imagery Questionnaire-Revised (MIQ-R questionaire).

top score 56 and bottom score 8. The higher values indicates a better outcome.

Change from baseline at 2 weeks
Psychological factors_Anxiety
Time Frame: Change from baseline at 2 weeks
State Trait Anxiety Inventory (STAI-T). Top score 60 and bottom score 0. The higher values indicate worst outcomes.
Change from baseline at 2 weeks
Psychological factors_Depression
Time Frame: Change from baseline at 2 weeks

Beck Depression Inventory (BDI-II). the scores goes from 0 to 63. The higher values indicate worst outcomes.

Beck Depression Inventory (BDI-II)

Beck Depression Inventory (BDI-II)

Change from baseline at 2 weeks
Psychological factors_Kinesiophobia
Time Frame: Change from baseline at 2 weeks
Tampa Scale for Kinesiophobia. Total scores goes from 11 to 44.The higher values indicate worst outcomes.
Change from baseline at 2 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 8, 2019

Primary Completion (Actual)

January 31, 2020

Study Completion (Actual)

February 25, 2020

Study Registration Dates

First Submitted

August 9, 2019

First Submitted That Met QC Criteria

September 9, 2019

First Posted (Actual)

September 11, 2019

Study Record Updates

Last Update Posted (Actual)

June 8, 2021

Last Update Submitted That Met QC Criteria

June 7, 2021

Last Verified

June 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • 2703201906919

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Median Nerve Injury

Clinical Trials on Mirror therapy

Subscribe